US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

665.74

-8.4209-1.25%

Number of Gainers:70

Number of Losers:70

Number of Flat:13

PE:- -

High:687.10

Open:668.22

Low:665.46

Close:674.17

Volume:284.69M

Turnover:11.42B

Market Cap:459.41B

Float Cap:358.92B

Loading ...

Silexion Therapeutics Announces Exercise of Warrants

Acurx Pharmaceuticals Announces First Patient Enrolled in Pathfinder Clinical Trial of Ibezapolstat in Multiply-Recurrent C. Difficile Infection

THOMSON REUTERS

Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda

European Wax Center Announces Renowned Esthetician Joanna Czech as First-Ever Brand Ambassador

US Stocks on the MOVE-PepsiCo, Coinbase Global, CarMax

Aquestive Therapeutics Adds Veteran Executive to Board

Zhihu-W (02390) Spends US$265,100 to Buy Back 207,900 Shares on September 28

Invivyd Plans FDA Accelerated-Approval BLA Filing for Vyd2311 COVID Antibody

Deutsche Bank Trims Price Target on Robinhood Markets to $134 From $138, Keeps Buy Rating

MT Newswires Live

Unicycive Therapeutics announces resubmission of NDA for OLC

Aquestive Therapeutics appoints Daly to board of directors

Unicycive Resubmits FDA NDA for Oxylanthanum Carbonate Phosphate Binder

Unicycive Therapeutics - FDA Acceptance of Nda Expected Within 30 Days; New Pdufa Date in 6 Months

THOMSON REUTERS

Unicycive Therapeutics - Nda Resubmission Includes Cmc Data from New Manufacturing Vendor

THOMSON REUTERS

Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate

THOMSON REUTERS

Unicycive Therapeutics - FDA Inspection of Original Manufacturing Vendor Assigned but not Completed as of Sept 29, 2026

THOMSON REUTERS

Invivyd Says Liberty Phase 3 Trial Shows Vyd2311 Safety, Tolerability Top mRNA COVID-19 Vaccine

Invivyd, - Vyd2311 Combined with Mrna Covid-19 Vaccine Adds to Neutralizing Titers Without Interference

THOMSON REUTERS

Invivyd, - Plans Bla Submission for Vyd2311 to FDA Via Accelerated Approval Program

THOMSON REUTERS

Invivyd Announces Positive Topline Results from Liberty Phase 3 Study Demonstrating Vyd2311 Safety and Tolerability Superior to Mrna-Based Covid-19 Vaccine; Announces Regulatory Submission Plans for Vyd2311

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/BK4539/news?page=17"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":665.74475,"timestamp":1790971199999,"preClose":674.16565,"halted":0,"volume":284690200,"delay":0,"changeRate":-0.012491,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-8.420898,"latestTime":"10-02 16:00:00 EDT","open":668.2159,"high":687.09705,"low":665.4622,"amount":11415788801.016344,"amplitude":0.032091,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.17484,"peRate":114.229173,"turnoverRate":0.022399,"increases":70,"decrements":70,"flats":10,"marketCap":459409451462.5,"floatMarketCap":358922617098.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":687.09705,"amplitude":0.032091,"preClose":674.16565,"low":665.4622,"pbRate":"5.17484","latestPrice":665.74475,"volume":284690200,"delay":0,"open":668.2159,"prevYearClose":881.5255,"prevWeekClose":697.624,"prevMonthClose":677.2829,"prevQuarterClose":677.2829,"fiveDayClose":697.624,"twentyDayClose":733.4782,"sixtyDayClose":783.9062,"secType":"PLATE","market":"US","turnoverRate":0.022399,"peRate":114.229173,"marketCap":459409451462.5,"floatMarketCap":358922617098.875,"timestamp":1790971199999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":70,"down":70,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:17,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671119472","title":"Silexion Therapeutics Announces Exercise of Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2671119472","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671119472?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:03","pubTimestamp":1790683380,"startTime":"0","endTime":"0","summary":"Cayman Islands, Sept.  29, 2026 (GLOBE NEWSWIRE) --  Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3370802/0/en/silexion-therapeutics-announces-exercise-of-warrants.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLXN","BK4007","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211311","title":"Acurx Pharmaceuticals Announces First Patient Enrolled in Pathfinder Clinical Trial of Ibezapolstat in Multiply-Recurrent C. Difficile Infection","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211311","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211311?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:01","pubTimestamp":1790683260,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA7C8Z5T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","BK4563","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211940","title":"Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211940","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211940?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683200,"startTime":"0","endTime":"0","summary":"LEXINGTON, Mass., Sept.  29, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel ther","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3370744/0/en/keros-therapeutics-to-receive-additional-development-milestone-payment-from-partner-takeda.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4539","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211158","title":"European Wax Center Announces Renowned Esthetician Joanna Czech as First-Ever Brand Ambassador","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211158","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211158?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683200,"startTime":"0","endTime":"0","summary":"The celebrity esthetician will serve as Chief Smooth Officer, bringing her skincare expertise to the waxing journey as EWC ushers in its new “Smooth, Done Right” brand platform PLANO, Texas, Sept.  29","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3370785/0/en/european-wax-center-announces-renowned-esthetician-joanna-czech-as-first-ever-brand-ambassador.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWCZ","BK4582","BK4539","EPV","EWC","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671197702","title":"US Stocks on the MOVE-PepsiCo, Coinbase Global, CarMax","url":"https://stock-news.laohu8.com/highlight/detail?id=2671197702","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671197702?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:52","pubTimestamp":1790682734,"startTime":"0","endTime":"0","summary":"BUZZ-US STOCKS ON THE MOVE-PepsiCo, Coinbase Global, CarMaxSeptember 29 (Reuters)-US stock index futures traded sideways on Tuesday, though tech and AI-linked stocks ticked higher, as rising crude oil","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL6N45L0PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBLC","IE00BN8TJ469.HKD","IE0000B7K699.USD","FIAT","LU0868494708.USD","IE000SO60NU8.SGD","LU1868836757.USD","IE0034235188.USD","LU1668664300.SGD","COIN","GSX","LU2265009873.SGD","COIX","BK4554","IE000WAW04H5.SGD","IE0004091025.USD","07711","LU0320765646.SGD","09311","BK4539","IE00BFXG1179.USD","LU0106831901.USD","LU1894683348.USD","LU2237443978.SGD","LU2896262040.SGD","BK4516","BK4566","LU1894683264.USD","LU0096364046.USD","LU0098860793.USD","CONY","LU0251142724.SGD","LU2471134952.CNY","LU2750360641.GBP","LU0345770993.USD","BK4127","CONL","LU0868494617.USD","IE00BLSP4239.USD","LU2237443622.USD","LU1929549753.HKD","LU1804176565.USD","IE000F7OJYX1.SGD","BITQ","BK4214","FDIG","COYY","BLCK","LU2360107671.USD","LU1244550221.USD","BK4552","LU0048573561.USD","BK4551","BK4550","IE000BZT7R73.USD","IE00BLSP4452.SGD","LU0345770308.USD","LU2237443382.USD","LU0210536198.USD","IE00B19Z3581.USD","BK4535","LU1861220207.SGD","LU1868837300.USD","LU1244550577.SGD","LU2471134796.USD","BK4112","07311","LU0061475181.USD","BK4187","BK4504","BK4585","LU1868836591.USD","LU2471134523.USD","BK4177","COIW","IE00B7SZL793.SGD","BK4588","BK4596","BK4572","BK4533","LU1791807156.HKD","IE0002270589.USD","LU0742534661.SGD","LU1868836914.USD","LU1861558580.USD","LU1244550494.USD","BKCH","BK4600","KMX","COIO","LU1868837136.USD","IE00BBT3K403.USD","LU0234572021.USD","IE0004086264.USD","IE00B66KJ199.SGD","ICOI","CONX","COIG","LU1861559042.SGD","BK4534","LU0251131958.USD","FINX","CONI","LU2750360997.AUD","AIR","BK4595","LU2237443465.HKD","LU1861217088.USD","BK4581","COIA","IE00B3T34201.USD","GS","LU2237443549.SGD","09711","IE00B19Z3B42.SGD","IE000MB6IJN5.SGD","LU1144417596.USD","FTXG","COII","DAPP","IE0031619046.USD","LU2471134879.HKD","LU1162221912.USD","LU2237438978.USD","PEP","IE00BSNM7G36.USD","LU0942090050.USD","IE00B19Z4B17.USD","LU2237443895.HKD","CRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211508","title":"Aquestive Therapeutics Adds Veteran Executive to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211508","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211508?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:49","pubTimestamp":1790682582,"startTime":"0","endTime":"0","summary":"Aquestive Therapeutics ( ($AQST) ) has provided an update. On September 29, 2026, Aquestive Therapeutics announced that its board had elected veter...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aquestive-therapeutics-adds-veteran-executive-to-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aquestive-therapeutics-adds-veteran-executive-to-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198995429","title":"Zhihu-W (02390) Spends US$265,100 to Buy Back 207,900 Shares on September 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1198995429","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198995429?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:38","pubTimestamp":1790681892,"startTime":"0","endTime":"0","summary":"Zhihu-W (02390) has announced that on September 28, 2026, the company spent US$265,100 to repurchase 207,900 shares, at a repurchase price of HK$1.25 to HK$1.2933 per share.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4509","BK4077","HK0000252160.HKD","HK0000252152.HKD","HK0000500386.USD","BK4539","02390","BK1095","ZH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216770","title":"Invivyd Plans FDA Accelerated-Approval BLA Filing for Vyd2311 COVID Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216770","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216770?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:28","pubTimestamp":1790681317,"startTime":"0","endTime":"0","summary":"Invivyd plans FDA accelerated-approval BLA filing for VYD2311 COVID antibodyInvivyd set plans to file a U.S. FDA Biologics License Application for COVID-19 antibody VYD2311 via the Accelerated Approva","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL4XrsY1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216711","title":"Deutsche Bank Trims Price Target on Robinhood Markets to $134 From $138, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216711","media":"MT Newswires Live","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216711?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:25","pubTimestamp":1790681148,"startTime":"0","endTime":"0","summary":"Robinhood Markets (HOOD) has an average rating of overweight and mean price target of $134.74, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HOOD","BK4539","HOOY","ROBN","LU1861559042.SGD","BLCK","IAI","HOII","HODU","HOOG","HOOC","BK4547","HOOX","CRPT","FINX","HOYY","BK4127","HOOW","BPAY","HOOI","HOOZ","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216406","title":"Unicycive Therapeutics announces resubmission of NDA for OLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216406","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216406?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:15","pubTimestamp":1790680531,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics (UNCY) announced the resubmission of its New Drug Application, NDA, for oxylanthanum carbonate, OLC, the Company’s investiga...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-announces-resubmission-of-nda-for-olc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-announces-resubmission-of-nda-for-olc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671921643","title":"Aquestive Therapeutics appoints Daly to board of directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2671921643","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671921643?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:10","pubTimestamp":1790680210,"startTime":"0","endTime":"0","summary":"Aquestive Therapeutics (AQST) announced the appointment of Rich Daly to the Company’s Board of Directors, effective October 14, 2026. Following Mr....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aquestive-therapeutics-appoints-daly-to-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aquestive-therapeutics-appoints-daly-to-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4007","AQST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671421639","title":"Unicycive Resubmits FDA NDA for Oxylanthanum Carbonate Phosphate Binder","url":"https://stock-news.laohu8.com/highlight/detail?id=2671421639","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671421639?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679917,"startTime":"0","endTime":"0","summary":"Unicycive resubmits FDA NDA for oxylanthanum carbonate phosphate binderUnicycive resubmitted its FDA NDA for oxylanthanum carbonate to treat hyperphosphatemia in CKD patients on dialysis.Filing includ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL2RqzJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","SG9999014013.SGD","LU2095319765.USD","SG9999014021.USD","BK4585","BK4588","IE00B3QW5Z07.USD","BCDF","IE00BN0W2V16.EUR","NDAQ","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","LU0314104364.USD","LU2210150020.SGD","BK4539","IE00BQXX3F31.USD","UNCY","SG9999014005.SGD","BK4139","SG9999014039.USD","BK4112","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671521637","title":"Unicycive Therapeutics - FDA Acceptance of Nda Expected Within 30 Days; New Pdufa Date in 6 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2671521637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671521637?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216374","title":"Unicycive Therapeutics - Nda Resubmission Includes Cmc Data from New Manufacturing Vendor","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216374?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216370","title":"Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216370","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216370?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216306","title":"Unicycive Therapeutics - FDA Inspection of Original Manufacturing Vendor Assigned but not Completed as of Sept 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216306","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216306?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216388","title":"Invivyd Says Liberty Phase 3 Trial Shows Vyd2311 Safety, Tolerability Top mRNA COVID-19 Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216388","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216388?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:04","pubTimestamp":1790679843,"startTime":"0","endTime":"0","summary":"Invivyd says LIBERTY Phase 3 trial shows VYD2311 safety, tolerability top mRNA COVID-19 vaccineInvivyd reported positive topline Phase 3 LIBERTY results for VYD2311, already released, showing better s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL9g3Y2d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2095319765.USD","IVVD","SG9999014039.USD","IE00BQXX3D17.EUR","BK4539","SG9999014021.USD","IE00BQXX3F31.USD","BK4585","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","BK4112","BK4139","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BQXX3C00.GBP","SG9999014013.SGD","BK4588","LU0314104364.USD","BCDF","SG9999014005.SGD","IE00BN0W2V16.EUR","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671786215","title":"Invivyd, - Vyd2311 Combined with Mrna Covid-19 Vaccine Adds to Neutralizing Titers Without Interference","url":"https://stock-news.laohu8.com/highlight/detail?id=2671786215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671786215?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:01","pubTimestamp":1790679660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA9SJPNV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IVVD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215034","title":"Invivyd, - Plans Bla Submission for Vyd2311 to FDA Via Accelerated Approval Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215034","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671215034?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:01","pubTimestamp":1790679660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA9SJPNV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVVD","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671021573","title":"Invivyd Announces Positive Topline Results from Liberty Phase 3 Study Demonstrating Vyd2311 Safety and Tolerability Superior to Mrna-Based Covid-19 Vaccine; Announces Regulatory Submission Plans for Vyd2311","url":"https://stock-news.laohu8.com/highlight/detail?id=2671021573","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671021573?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:01","pubTimestamp":1790679660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA9SJPNV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":40,"pageCount":17,"totalSize":784,"code":"91000000","status":"200"}]}}